AbbVie Inc. Accounts Payable 2012-2025 | ABBV
Beta
What is accounts payable?
Accounts payable represents money the company owes to suppliers for goods or services received but not yet paid for.
What is AbbVie Inc.'s current accounts payable?
AbbVie Inc. (ABBV) annual accounts payable for 2025 was $3.59B, a 21.97% increase from 2024. AbbVie Inc. accounts payable for the quarter ending December 31, 2025 was $3.59B.
What was AbbVie Inc.'s accounts payable in 2024?
AbbVie Inc. annual accounts payable for 2024 was $2.94B, a 20.15% decline from 2023.
What was AbbVie Inc.'s accounts payable in 2023?
AbbVie Inc. annual accounts payable for 2023 was $3.69B, a 25.70% increase from 2022.
What is AbbVie Inc.'s 5-year accounts payable CAGR?
AbbVie Inc. accounts payable grew at a compound annual growth rate (CAGR) of 9.56% from FY2020 to FY2025, going from $2.28B to $3.59B over 5 years.
Accounts Payable History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+9.6%
FY2020
$2.28B
→
FY2025
$3.59B
1213141516171819202122232425
5 years selected
Accounts Payable History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $3.59B | +22.0% | 10-K |
| FY2024 | $2.94B | -20.1% | 10-K |
| FY2023 | $3.69B | +25.7% | 10-K |
| FY2022 | $2.93B | +1.8% | 10-K |
| FY2021 | $2.88B | +26.6% | 10-K |
| FY2020 | $2.28B | +56.7% | 10-K |
| FY2019 | $1.45B | -6.1% | 10-K |
| FY2018 | $1.55B | +4.9% | 10-K |
| FY2017 | $1.47B | +4.8% | 10-K |
| FY2016 | $1.41B | -11.9% | 10-K |
| FY2015 | $1.60B | +14.0% | 10-K |
| FY2014 | $1.40B | +50.2% | 10-K |
| FY2013 | $933.0M | +67.8% | 10-K |
| FY2012 | $556.0M | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →